Roth Capital Partners Announces the Addition of John Boris to its Healthcare Investment Banking Team

NEWPORT BEACH, Calif.--()--Roth Capital Partners (“Roth”), www.roth.com, a full service investment bank focused on serving emerging growth companies and their investors, today announced that John Boris has joined the firm's Healthcare Investment Banking team as a Managing Director.

Prior to joining Roth, Mr. Boris was the Managing Partner of JTB Capital Management, where he invested in private and public biopharmaceutical companies. Previously, Mr. Boris was a Senior Managing Director in the Equity Research Groups at SunTrust Robinson Humphreys, Citigroup, and Bear Stearns, LLC where he led top ranked teams recognized by Institutional Investor Magazine. Mr. Boris is also the recipient of the StarMine Thomson Reuters Award for being Wall Street's Top Stock Picker in Pharmaceuticals. Prior to 1998, Mr. Boris worked in the pharmaceutical industry in strategic and operational roles as a senior manager at Warner Lambert, and at Eli Lilly and Company.

“We are excited to have John join our team and build on his strong background and focus on the healthcare space. We continue to take advantage of opportunities for expansion by adding professionals in sectors which we believe are aligned with our small cap growth focus,” stated Byron Roth, CEO of Roth Capital Partners.

Mr. Boris commented, “I am excited to join Roth, an investment bank with a long established history of servicing emerging development stage healthcare companies. I look forward to working with the Roth Healthcare Investment Banking Team to offer strategic advice to healthcare companies, and to help them achieve their strategic and financial goals.”

Mr. Boris received his MBA in finance from the Columbia University Graduate School of Business, and B.S. in Pharmacy from the Philadelphia College of Pharmacy & Sciences. He also graduated Summa Cum Laude from the Valley Forge Military College with an additional degree in science.

Since 2010, Roth has been involved in over 520 transactions for its Healthcare clients with a total transaction value of over $24 billion. (Source: Roth Capital Partners | 05.17.21)

About Roth Capital Partners, LLC:

Roth Capital Partners, LLC (Roth), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, Roth provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access.

Headquartered in Newport Beach, Calif., Roth is privately-held and owned by its employees, and maintains offices throughout the U.S. For more information on ROTH, please visit www.roth.com.

Contacts

Investor and Media Contact:
Roth Capital Partners, Isabel Mattson-Pain, Director of Marketing, Imattson-pain@roth.com, 949-720-7117

Release Summary

Roth Capital Partners Announces the Addition of John Boris to its Healthcare Investment Banking Team

Contacts

Investor and Media Contact:
Roth Capital Partners, Isabel Mattson-Pain, Director of Marketing, Imattson-pain@roth.com, 949-720-7117